Irish Medicines Database · HPRA register

Kyinsu (700 units + 2 mg)/mL solution for injection in pre-filled pen

Authorisation EU/1/25/1992/001-006 · Novo Nordisk A/S

Licence EU/1/25/1992/001-006 · Unknown

Licence holder: Novo Nordisk A/S (all products →)
Active substances: Insulin icodec, Semaglutide
Dosage form: Solution for injection in pre-filled pen
Route of administration: Subcutaneous use
ATC code: A10AE57
First authorised: 24/11/2025
Prescription status: Product subject to prescription which may not be renewed (A)
Supply: Supply through pharmacies only
Legal basis: Fixed combination application (Article 10b of Directive No 2001/83/EC)

Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 16 Sep 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.